Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry

Trial Profile

Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2018

At a glance

  • Drugs Liraglutide (Primary) ; Glucagon like peptide 1 receptor agonists
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Feb 2018 Planned End Date changed from 1 Dec 2027 to 1 Dec 2035.
    • 26 Feb 2018 Planned primary completion date changed from 1 Dec 2027 to 1 Dec 2035.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top